NOVEL QUINAZOLINE EGFR INHIBITORS
This document discloses a novel class of quinazoline EGFR inhibitors. Also disclosed are pharmaceutical compositions thereof and method for treating cancers. Disclosed herein is a novel class of quinazoline compounds which selectively and effectively inhibit the growth of cancer cells induced by the...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English French German |
Published |
17.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This document discloses a novel class of quinazoline EGFR inhibitors. Also disclosed are pharmaceutical compositions thereof and method for treating cancers. Disclosed herein is a novel class of quinazoline compounds which selectively and effectively inhibit the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor (EGFR). |
---|---|
Bibliography: | Application Number: EP20190862092 |